Key Points Tirzepatide works on two hormone pathways (GLP-1 and GIP) while semaglutide targets one pathway (GLP-1) that reduces appetite and controls blood sugar levels In a direct comparison, tirzepatide helped people lose more weight, on average Both medications require weekly injections and have similar side effects, like nausea and digestive issues Additionally, semaglutide has FDA approval for heart protection benefits, while tirzepatide is approved for sleep apnea treatment Both tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) are transforming how doctors treat type 2 diabetes and obesity, but they're not identical medications
Methodological framework and research design Search strategy and inclusion criteria This study is explicitly designed as a structured narrative review
Medullary thyroid cancer Gallbladder issues Anaphylaxis (severe allergic reaction) Seek immediate medical attention if you experience any severe symptoms on a GLP-1 or other medication
"What's so interesting about this category is that people care about their weight in a way that they don't care about their A1C or their hypertension
Researchers have also observed improvements in oxidative stress markers and endothelial health, which reflect the effect of GLP 1s on blood vessels and cellular inflammation
